Executive Briefings

FDA Moves Forward on E-Pedigree System for Pharmaceuticals

With public comments in from about 55 sources, the U.S. Food and Drug Administration is now proceeding to prepare a recommendation for an electronic pedigree (e-pedigree) system that pharmaceutical makers, distributors and retailers would be required to use to identify products as they moved through the supply chain. The track-and-trace solution would be used to not only record which parties handled a drug during shipment but to also verify its authenticity and thwart counterfeiting. The FDA was accepting public comment until May 19, and now it will begin the process of analyzing those comments before making its recommendation as to how drugs would be tracked, what technology and what standards might be used, and who could help create those standards.
Source: RFID Journal, http://www.rfidjournal.com

With public comments in from about 55 sources, the U.S. Food and Drug Administration is now proceeding to prepare a recommendation for an electronic pedigree (e-pedigree) system that pharmaceutical makers, distributors and retailers would be required to use to identify products as they moved through the supply chain. The track-and-trace solution would be used to not only record which parties handled a drug during shipment but to also verify its authenticity and thwart counterfeiting. The FDA was accepting public comment until May 19, and now it will begin the process of analyzing those comments before making its recommendation as to how drugs would be tracked, what technology and what standards might be used, and who could help create those standards.
Source: RFID Journal, http://www.rfidjournal.com